OPKO Health acquires EirGen Pharma
OPKO Health announced the acquisition of EirGen Pharma, a based specialty pharmaceutical company focused on development and commercial supply of high potency pharmaceutical products for sale in the U.S., Canada, Japan, Australia, most European countries, and more than 40 others around the world. May 05, 2015